Doxazocin in management of benign prostatic hyperplasia
A total 220 patients with benign prostatic hyperplasia (BPH) but not having absolute indication for surgery were enrolled for 8 weeks single label study, using doxazocin (Doxacard) 4 mg daily for their features of prostatism, with a six month follow up. The study revealed an improve-ment of 90% in t...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2003-01-01
|
| Series: | Indian Journal of Urology |
| Subjects: | |
| Online Access: | http://www.indianjurol.com/article.asp?issn=0970-1591;year=2003;volume=19;issue=2;spage=113;epage=116;aulast=Mohanty |
| _version_ | 1811266697153216512 |
|---|---|
| author | N K Mohanty R P Arora A K Jha S Singh Pal |
| author_facet | N K Mohanty R P Arora A K Jha S Singh Pal |
| author_sort | N K Mohanty |
| collection | DOAJ |
| description | A total 220 patients with benign prostatic hyperplasia (BPH) but not having absolute indication for surgery were enrolled for 8 weeks single label study, using doxazocin (Doxacard) 4 mg daily for their features of prostatism, with a six month follow up. The study revealed an improve-ment of 90% in their symptoms at the end of the study with an increase of maximum flow rate (MFR) by 5-5.5 ml/sec and average flow rate (AFR) 2.5-3 ml/sec. Adverse effects were minimum and patient compliance was very good with good drug tolerability. Our study strongly supports the use of doxazocin as an alternative in the management of uncomplicated BPH with hypertension. |
| first_indexed | 2024-04-12T20:47:56Z |
| format | Article |
| id | doaj.art-3aad95378774467794837abf371504b3 |
| institution | Directory Open Access Journal |
| issn | 0970-1591 1998-3824 |
| language | English |
| last_indexed | 2024-04-12T20:47:56Z |
| publishDate | 2003-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Indian Journal of Urology |
| spelling | doaj.art-3aad95378774467794837abf371504b32022-12-22T03:17:12ZengWolters Kluwer Medknow PublicationsIndian Journal of Urology0970-15911998-38242003-01-01192113116Doxazocin in management of benign prostatic hyperplasiaN K MohantyR P AroraA K JhaS Singh PalA total 220 patients with benign prostatic hyperplasia (BPH) but not having absolute indication for surgery were enrolled for 8 weeks single label study, using doxazocin (Doxacard) 4 mg daily for their features of prostatism, with a six month follow up. The study revealed an improve-ment of 90% in their symptoms at the end of the study with an increase of maximum flow rate (MFR) by 5-5.5 ml/sec and average flow rate (AFR) 2.5-3 ml/sec. Adverse effects were minimum and patient compliance was very good with good drug tolerability. Our study strongly supports the use of doxazocin as an alternative in the management of uncomplicated BPH with hypertension.http://www.indianjurol.com/article.asp?issn=0970-1591;year=2003;volume=19;issue=2;spage=113;epage=116;aulast=Mohantyα - aldernericdoxazocinDoxacard. |
| spellingShingle | N K Mohanty R P Arora A K Jha S Singh Pal Doxazocin in management of benign prostatic hyperplasia Indian Journal of Urology α - alderneric doxazocin Doxacard. |
| title | Doxazocin in management of benign prostatic hyperplasia |
| title_full | Doxazocin in management of benign prostatic hyperplasia |
| title_fullStr | Doxazocin in management of benign prostatic hyperplasia |
| title_full_unstemmed | Doxazocin in management of benign prostatic hyperplasia |
| title_short | Doxazocin in management of benign prostatic hyperplasia |
| title_sort | doxazocin in management of benign prostatic hyperplasia |
| topic | α - alderneric doxazocin Doxacard. |
| url | http://www.indianjurol.com/article.asp?issn=0970-1591;year=2003;volume=19;issue=2;spage=113;epage=116;aulast=Mohanty |
| work_keys_str_mv | AT nkmohanty doxazocininmanagementofbenignprostatichyperplasia AT rparora doxazocininmanagementofbenignprostatichyperplasia AT akjha doxazocininmanagementofbenignprostatichyperplasia AT ssinghpal doxazocininmanagementofbenignprostatichyperplasia |